Two Experts Take on Biotech: TheStockAdvisors.com Features John McCamant and Michael Shulman

Share Article

TheStockAdvisors.com (http://www.thestockadvisors.com), an interactive guide to financial newsletters announced today that it has provided readers with comments from two leading stock advisory groups. John McCamant and Michael Shulman comment on their outlook for two biotech companies BioCryst (BCRX: NASDAQ) and Genetech (DNA: NYSE).

TheStockAdvisors.com (http://www.thestockadvisors.com), an interactive guide to financial newsletters announced today that it has provided readers with comments from two leading stock advisory groups. John McCamant and Michael Shulman comment on their outlook for two biotech companies BioCryst (BCRX: NASDAQ) and Genetech (DNA: NYSE).

When it comes to biotech stocks, few advisors have the long-standing expertise enjoyed by John McCamant. His success in finding opportunities among biotech stocks for his Medical Technology Stock Letter is based not just on analytic skills, but an in-depth understanding of the research underlying the sector, as well as direct contact and experience with researchers, analysts, venture capitalists, and executives in the sector.

Go direct to the full article: http://www.thestockadvisors.com/content/view/149/9/

"What is the most promising new technological or scientific approach as a long-term investment? The answer is personalized medicine -- including several trends currently in scientific development. Personalized medicine -- called ‘ME’ medicine -- is a very broad category of development categories and companies. The stocks in this emerging area are not yet in favor among institutional investors. The Street does not yet believe in most personalized treatments and this creates a great opportunity for us. Here, the editor of ChangeWave Biotech Investor looks at “the next great drug company.”

Go direct to the full article: http://www.thestockadvisors.com/content/view/55/9/

All readers on TheStockAdvisors.com receive free access to professional commentary and research from the top investing newsletters and their advisors.

TheStockAdvisors.com also offers a bi-weekly email which offers the best picks from the week’s posts. Subscribe for free at the sign-up box on our site: http://www.thestockadvisors.com

About TheStockAdvisors.com:

TheStockAdvisors.com is the first ever interactive site for individual investors and financial newsletter advisors. Steven Halpern, the editor of TheStockAdvisors.com, with his 24 years of experience as a financial newsletter editor, has set a goal to help investors learn from the most qualified, unbiased, and independent financial newsletter advisors.

We encourage users to actively participate in interactive forums, share feedback, and support our participating advisors. To subscribe to any of our featured newsletters, all names are conveniently linked to their respective websites.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Eric Levitt
Visit website